{
 "drug": "Rifampin Injection",
 "asOf": "2026-08-25",
 "status": "in-shortage",
 "since": "02/17/2021",
 "dayN": 2015,
 "cat": "Anti-Infective",
 "companies": [
  "Fresenius Kabi USA, LLC",
  "Sanofi-Aventis U.S. LLC",
  "Mylan Institutional, a Viatris Company"
 ],
 "reasons": [
  "Delay in shipping of the drug",
  "Discontinuation of the manufacture of the drug",
  "Demand increase for the drug"
 ],
 "records": [
  {
   "update_type": "Reverified",
   "initial_posting_date": "02/17/2021",
   "package_ndc": "63323-351-20",
   "generic_name": "Rifampin Injection",
   "contact_info": "888-386-1300",
   "availability": "Unavailable",
   "related_info": "Next release August 2026. Check wholesalers for inventory.",
   "openfda": {
    "application_number": [
     "ANDA091181"
    ],
    "brand_name": [
     "RIFAMPIN"
    ],
    "generic_name": [
     "RIFAMPIN"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "63323-351"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "RIFAMPIN"
    ],
    "rxcui": [
     "312821"
    ],
    "spl_id": [
     "60eb9c46-3c34-455b-a740-c03884565072"
    ],
    "spl_set_id": [
     "a1f9f1e2-dfc0-4d31-a13b-b656d897b791"
    ],
    "package_ndc": [
     "63323-351-20"
    ],
    "nui": [
     "N0000175500",
     "M0019113"
    ],
    "pharm_class_epc": [
     "Rifamycin Antibacterial [EPC]"
    ],
    "pharm_class_cs": [
     "Rifamycins [CS]"
    ],
    "unii": [
     "VJT6J7R4TR"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Anti-Infective"
   ],
   "dosage_form": "Injection",
   "presentation": "Rifampin, Injection, 600 mg (NDC 63323-351-20)",
   "company_name": "Fresenius Kabi USA, LLC",
   "shortage_reason": "Delay in shipping of the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "02/17/2021",
   "package_ndc": "0068-0597-01",
   "generic_name": "Rifampin Injection",
   "related_info_link": "https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Rifampin%20Injection&st=d",
   "contact_info": "800-633-1610",
   "availability": "Unavailable",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "NDA050627"
    ],
    "brand_name": [
     "RIFADIN IV"
    ],
    "generic_name": [
     "RIFAMPIN"
    ],
    "manufacturer_name": [
     "Sanofi-Aventis U.S. LLC"
    ],
    "product_ndc": [
     "0068-0597"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "RIFAMPIN"
    ],
    "rxcui": [
     "207436",
     "312821"
    ],
    "spl_id": [
     "82e2bbb1-cc73-4fbd-8d85-610634876355"
    ],
    "spl_set_id": [
     "036ab68e-5085-4edc-bd83-784b43d64eab"
    ],
    "package_ndc": [
     "0068-0597-01"
    ],
    "nui": [
     "N0000175500",
     "M0019113"
    ],
    "pharm_class_epc": [
     "Rifamycin Antibacterial [EPC]"
    ],
    "pharm_class_cs": [
     "Rifamycins [CS]"
    ],
    "unii": [
     "VJT6J7R4TR"
    ]
   },
   "update_date": "06/22/2026",
   "therapeutic_category": [
    "Anti-Infective"
   ],
   "dosage_form": "Injection",
   "presentation": "Rifadin, Injection, 600 mg (NDC 0068-0597-01)",
   "company_name": "Sanofi-Aventis U.S. LLC",
   "shortage_reason": "Discontinuation of the manufacture of the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "02/17/2021",
   "package_ndc": "67457-445-60",
   "generic_name": "Rifampin Injection",
   "contact_info": "800-796-9526",
   "availability": "Unavailable",
   "related_info": "Estimated recovery: Q4 2026",
   "openfda": {
    "application_number": [
     "ANDA065421"
    ],
    "brand_name": [
     "RIFAMPIN"
    ],
    "generic_name": [
     "RIFAMPIN"
    ],
    "manufacturer_name": [
     "Mylan Institutional LLC"
    ],
    "product_ndc": [
     "67457-445"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "RIFAMPIN"
    ],
    "rxcui": [
     "312821"
    ],
    "spl_id": [
     "2e65f8eb-0189-46db-9458-98ef7f67a156"
    ],
    "spl_set_id": [
     "8be91604-d7cd-4f2b-997d-e3364e4092e5"
    ],
    "package_ndc": [
     "67457-445-60"
    ],
    "nui": [
     "N0000175500",
     "M0019113"
    ],
    "pharm_class_epc": [
     "Rifamycin Antibacterial [EPC]"
    ],
    "pharm_class_cs": [
     "Rifamycins [CS]"
    ],
    "unii": [
     "VJT6J7R4TR"
    ]
   },
   "update_date": "08/20/2026",
   "therapeutic_category": [
    "Anti-Infective"
   ],
   "dosage_form": "Injection",
   "presentation": "Rifampin, Injection, 600 mg (NDC 67457-445-60)",
   "company_name": "Mylan Institutional, a Viatris Company",
   "shortage_reason": "Demand increase for the drug",
   "status": "Current"
  },
  {
   "discontinued_date": "04/20/2026",
   "update_type": "New",
   "initial_posting_date": "04/20/2026",
   "package_ndc": "0068-0597-01",
   "generic_name": "Rifampin Injection",
   "contact_info": "800-633-1610",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "NDA050627"
    ],
    "brand_name": [
     "RIFADIN IV"
    ],
    "generic_name": [
     "RIFAMPIN"
    ],
    "manufacturer_name": [
     "Sanofi-Aventis U.S. LLC"
    ],
    "product_ndc": [
     "0068-0597"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "RIFAMPIN"
    ],
    "rxcui": [
     "207436",
     "312821"
    ],
    "spl_id": [
     "82e2bbb1-cc73-4fbd-8d85-610634876355"
    ],
    "spl_set_id": [
     "036ab68e-5085-4edc-bd83-784b43d64eab"
    ],
    "package_ndc": [
     "0068-0597-01"
    ],
    "nui": [
     "N0000175500",
     "M0019113"
    ],
    "pharm_class_epc": [
     "Rifamycin Antibacterial [EPC]"
    ],
    "pharm_class_cs": [
     "Rifamycins [CS]"
    ],
    "unii": [
     "VJT6J7R4TR"
    ]
   },
   "update_date": "04/20/2026",
   "therapeutic_category": [
    "Anti-Infective"
   ],
   "dosage_form": "Injection",
   "presentation": "Rifadin, Injection, 600 mg/10 mL (NDC 0068-0597-01)",
   "company_name": "Sanofi-Aventis U.S. LLC",
   "status": "To Be Discontinued"
  }
 ]
}